0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global her 2 targeted drugs breast cancer market size status forecast 2019 2025.Your search for "" gave back 1533058 results.
Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Oncology Drugs market size was valued at USD 203160 million in 2023 and is forecast to a readjusted size of USD 392310 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Monoclonal antibody ADC drug is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies, and a complex formed by linking...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Lapatinib Ditosylate API market size was valued at US$ 13 million in 2023. With growing demand in downstream market, the Lapatinib...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Market Analysis and Insights: Global HER-2 Negative Breast Cancer Market The global HER-2 Negative Breast Cancer market is projected to grow from US...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2019 Summary Gamma Secretase (EC 3.4.23.) pipeline Target constitutes close to 21 molecules. Out...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
HR+/HER2-Breast Cancer Market Analysis and Insights: Global HR+HER2- Breast Cancer Market The global HR+HER2- Breast Cancer market is projected to...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Highlights The global HER-2 Negative Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
HR+/HER2-Breast Cancer Highlights The global HR+HER2- Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
